HIV-1 Drug Resistance Mutations in Children: A Systematic Review of Global Genotypic Evidence (2014–2026)
HIV-1 infection in children remains a major public health challenge, particularly in resource-limited settings where access to antiretroviral therapy (ART) and routine virological monitoring is limited. The emergence of HIV-1 drug resistance mutations (DRMs) compromises treatment efficacy and threatens long-term therap...